Platinum-Based Compounds for the Treatment of Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1421-9794|57|6|468-487

ISSN： 0009-3157

Source： Chemotherapy, Vol.57, Iss.6, 2012-01, pp. : 468-487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel combinations for the treatment of metastatic breast cancer

By Vahdat Linda T.  

Cancers, Vol. 2, Iss. 1, 2010-01 ,pp. : 1-19

MDPI

Access to resources Recommend Favorite

Acceptable but Limited Efficacy of Capecitabine-Based Doublets in the First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Pilot Study

By  

Chemotherapy, Vol. 59, Iss. 3, 2013-12 ,pp. : 207-213

Karger

Access to resources Recommend Favorite

Weight Loss Associated with Platinum-Based Chemotherapy in Patients with Advanced Lung Cancer

By  

Chemotherapy, Vol. 61, Iss. 5, 2016-04 ,pp. : 256-261

Karger

Access to resources Recommend Favorite

Concerns about Breast Cancer, Pain, and Fatigue in Non-Metastatic Breast Cancer Patients Undergoing Primary Treatment

By Amiel Chelsea R.   Fisher Hannah M.   Antoni Michael H.  

Healthcare, Vol. 4, Iss. 3, 2016-08 ,pp. : 62-62

MDPI

Access to resources Recommend Favorite

WISP1 Polymorphisms Contribute to Platinum-Based Chemotherapy Toxicity in Lung Cancer Patients

By Chen Juan   Yin Jiye   Li Xiangping   Wang Ying   Zheng Yi   Qian Chenyue   Xiao Ling   Zou Ting   Wang Zhan   Liu Junyan   Zhang Wei   Zhou Honghao   Liu Zhaoqian  

International Journal of Molecular Sciences, Vol. 15, Iss. 11, 2014-11 ,pp. : 21011-21027

MDPI

Access to resources Recommend Favorite